Clinical Characteristics, Co-Mutations, and Treatment Outcomes in Advanced Non-Small-Cell Lung Cancer Patients With the BRAF-V600E Mutation

Clinical Characteristics, Co-Mutations, and Treatment Outcomes in Advanced Non-Small-Cell Lung Cancer Patients With the BRAF-V600E Mutation

BackgroundLimited treatment outcome data is available for advanced non-small cell lung cancer (NSCLC) patients with BRAF V600E mutations. In this multicenter study, we describe therapeutic options and survival outcomes for patients with mutated BRAF V600E.MethodThis was a retrospective study in whic...

Full description

Bibliographic Details
Main Authors: Jingjing Qu, Qian Shen, Yuping Li, Farhin Shaheed Kalyani, Li Liu, Jianya Zhou, Jianying Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Oncology
Subjects:
non-small cell lung cancer
BRAF-V600E
dabrafenib plus trametinib
co-mutations
treatment outcomes
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.911303/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.911303/full

Similar Items